Professional Documents
Culture Documents
2023/3/30
收盤價 目標價
投資評價與建議
交易資料
投資建議中立:2023 年看好車載背光 Mini-LED、車燈、工控與儲源相關,消費性
潛在報酬率 (%) --
52 週還原收盤價區間 (NT$) 33.20-44.63
產品展望相對保守,ASP 下滑與匯率不力等因素,下修 2023 年稅後 EPS 至 2.61
市值 (NT$百萬元) 17670 元(前次預估稅後 EPS3.03 元),維持中立評等。
市值 (US$百萬美元) 580
流通在外股數 (百萬股) 443.00
ESG 評析
董監持股 (%) 7.00
外資持股 (%) 24.40 億光企業永續評鑑整體為 B+等,於 SASB 產業永續議題與跨產業五大永續面向平
投信持股 (%) 0.59 均得分分別為 B+等與 B+等。
融資使用率 (%) 2.71
SinoPac+ ESG 評鑑系統評等
財務資料
2022
股東權益 (NT$百萬元) 18,358
ROA (%) 4.35
ROE (%) 6.68
淨負債比率 (%) 28.27
公司簡介
主要客戶:
主要競爭對手:佰鴻、宏齊
永豐證券投資顧問股份有限公司 1
Please see penultimate page for additional important disclosures.
SinoPac Securities (SinoPac) is a foreign broker-dealer unregistered in the USA. SinoPac research is prepared by SinoPac Securities Investment Service, whose analysts are not registered in the USA. SinoPac research is distributed in
the USA pursuant to Rule 15a-6 of the Securities Exchange Act of 1934 solely by Rosenblatt Securities, an SEC registered and FINRA-member broker-dealer.
營運現況與分析
4Q22 認列業外損失,轉為虧損:受到大陸封城、烏俄戰爭、產業調整庫存等因素,
2022 年營收 199 億元(-20.5%YoY),稅後 EPS 2.78 元,其中 4Q22 因為清算 WOFI
導致毛利率下滑至 27.47%,業外因認列 WOFI 與工程損失,整體 4Q22 業外損失
1.9 億元,導致公司稅後 EPS-0.12 元,營運呈現虧損。2022 年營收比重:不可見光
佔 34%、照明佔 8%、背光佔 21%、消費性電子與手機佔 32%、其他佔 5%;
傳統光耦價格壓力大,中高階光耦展望仍佳:不可見光中光耦合器佔 50%以上,
光耦合器應用範圍廣泛,大宗應用在電源供應器相關,客戶涵蓋主要的電源供應器
大廠;2021 年光耦合器供不應求,2022 年隨著產能到位,IT 相關需求下滑,
Overbooking 等因素,整體不可見光營收呈現衰退,其中又以基礎型光耦合器
overbooking 較嚴重,價格壓力大;億光 2021 年布局高階光耦,2022 年開始發
酵,光耦中目前中高階光耦出貨已達 50%,2023 年工控、儲能應用展望仍佳,其
中歐洲、日本、台灣等重點工控客戶皆以切入,儲能超過 80%應用在中國市場,
預估 2023 年不可見光仍有機會雙位數的成長。
2
2023 年營收 195 億元(-2.57%YoY),毛利率 29.31%,稅後 EPS 3.03 元)。
附表一:當年度損益表
單位:百萬元 23Q1F 23Q2F 23Q3F 23Q4F 2023F
營業收入 4,300 4,408 5,525 5,526 19,760
營業毛利 1,166 1,207 1,554 1,553 5,480
營業利益 177 215 476 475 1,344
稅前淨利 217 294 514 504 1,528
稅後純益 164 223 389 382 1,159
稅後 EPS (元) 0.37 0.5 0.88 0.86 2.61
營收 QoQ 成長率 -3.50 2.51 25.34 0.02 --
營收 YoY 成長率 -22.03 -14.21 15.66 24.01 -0.64
毛利率 27.12 27.38 28.13 28.10 27.73
營益率 4.12 4.88 8.62 8.60 6.80
稅後純益率 3.81 5.06 7.04 6.91 5.87
資料來源:CMoney;永豐投顧研究處整理,Mar. 2023
附表二:五個年度損益表
單位:百萬元 2019 2020 2021 2022 2023F
營業收入 20,967 21,637 25,022 19,888 19,760
%變動率 -12.96 3.20 15.64 -20.52 -0.64
營業毛利 5,128 5,419 6,699 5,602 5,480
毛利率 (%) 24.46 25.04 26.77 28.17 27.73
營業淨利 835 1,354 2,415 1,470 1,344
稅前淨利 1,066 1,627 2,562 1,739 1,528
%變動率 -5.18 52.70 57.43 -32.11 -12.13
稅後純益 822 1,236 1,940 1,231 1,159
%變動率 3.68 50.34 56.91 -36.54 -5.85
稅後 EPS*(元) 1.86 2.79 4.37 2.78 2.61
市調 EPS*(元) 1.88 2.81 4.9 3.53 2.86
PER (×) 21.42 14.28 9.12 14.33 15.27
PBR (×) 1.05 1.01 0.96 0.96 0.91
每股淨值*(元) 38.00 39.62 41.68 41.40 44
每股股利 (元) 1.40 2.25 3.50 2.50 --
殖利率 (%) 4.78 6.08 7.26 6.77 --
*以目前股本計算
資料來源:CMoney;永豐投顧研究處整理,Mar. 2023
3
營運基本資料
同業比較
投資 目前 稅後 EPS PE PB
代號 公司 市值(億)
建議 股價 2022 2023 2022 2023 2022 2023
近三年單月營收狀況
千
3000000
2500000
2000000
1500000
1000000
500000
0
1 2 3 4 5 6 7 8 9 10 11 12
2023年 2022年 2021年
近三年單季營收 VS 毛利率趨勢圖
百萬 %
8000 35
30
6000 25
20
4000
15
2000 10
5
0 0
202001 202002 202003 202004 202101 202102 202103 202104 202201 202202 202203 202204
營業收入淨額(百萬) 毛利率(%)
負債比率 VS 存貨周轉天數
% 百
50 2
40
1.5
30
1
20
0.5
10
0 0
202001 202002 202003 202004 202101 202102 202103 202104 202201 202202 202203 202204
負債比率(%) 存貨週轉天數
4
歷史 PE 圖
NT$/share
15X
80 13X
11X
60 9X
7X
40 5X
20
0
2019 2020 2021 2022 2023
歷史 PB 圖
NT$/share
80
1.5X
60
1.3X
1.1X
40 0.9X
0.7X
20 0.5X
0
2019 2020 2021 2022 2023
資料來源:CMoney;永豐投顧研究處整理,Mar. 2023
近八季營業利益及毛利率趨勢圖
百萬 29% 29% %
600 28% 28% 28% 29%
200 27%
0 26%
1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23
營業利益(百萬) 毛利率
資料來源:CMoney;永豐投顧研究處整理,Mar. 2023
5
台北 永豐證券投資顧問股份有限公司 永豐金證券股份有限公司
台北市忠孝西路一段 80 號 14 樓 台北市重慶南路一段 2 號 17 樓
電話:(886-2) 2361-0868 電話:(886-2) 2311-4345
香港 永豐金證券(亞洲)有限公司
香港銅鑼灣新寧道 1 號 7 樓
電話:(852) 2586-8288
上海 永豐金證券(亞洲)有限公司上海代表處
中國上海市浦東新區世紀大道 1528 號陸家嘴基金大廈 1903A-2 室
電話:(86-21) 6228-8220
倫敦 永豐金證券(歐洲)有限公司
6 Lloyds Avenue, London EC3N 3AX, UK
電話:(44-20) 7614-9999
責任聲明
本報告內容僅供參考,客戶應審慎考量本身之需求與投資風險,本公司恕不負任何法律責任,
亦不作任何保證。本報告中之內容或有取材於本公司認可之來源,但並不保證其真實性或完
整性;報告中所有資訊或預估,變更時本公司將不作預告,若資料內容有未盡完善之處,恕
不負責。此外,非經本公司同意,不得將本報告加以複製或轉載。
資誠永續發展服務股份有限公司僅於ESG評鑑系統方法學建置過程中,就評分指標提
供專業意見,對於評分結果及評估報告內容之完整性及真實性,不負擔保責任,亦不對
閱讀或使用本評估報告之第三方負任何責任。
SinoPac 投資評等
B:Buy 買進:未來 12 個月該股票表現將優於大盤
N:Neutral 中立:未來 12 個月該股票表現將與大盤一致
S:Sell 賣出:未來 12 個月該股票表現將落後大盤
6
Analyst Certification:
For each company mentioned in this research report, the respective analyst(s) who cover the company certifies
(certify) that all of the views expressed in this research report accurately reflect his (their) personal views about
any and all of the subject issuer(s) or securities. The analyst(s) also certifies (certify) that no part of her (their)
compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this
report.
SinoPac Research Stock Rating System:
Buy: We think the stock will outperform the broader market over the next 12 months.
Neutral: We think the stock will perform in line with the broader market over the next 12 months.
Sell: We think the stock will underperform the market over the next 12 months.
Global Disclaimer:
Important Notice for UK Persons
This Document may only be issued or passed on to any person in the United Kingdom if that person is of a kind
described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2001 or
otherwise pursuant to exemptions to section 21 of the Financial Services and Markets Act 2000. In addition, no
person who is an Authorized Person may issue or pass on this document, or otherwise promote SPSE, to any
person in the United Kingdom other than by the rules of the Financial Conduct Authority (FCA) applicable to
such Authorized Persons. This Document is confidential and is intended solely for the use of its recipient.
Important Disclosures for U.S. Persons
This research report was prepared by SinoPac Securities Corporation (SinoPac), a company authorized to
engage in securities activities in Taiwan. SinoPac is not a registered broker-dealer in the United States and,
therefore, is not subject to U.S. rules regarding the preparation of research reports and the independence of
research analysts. This research report is provided for distribution to “major U.S. institutional investors” in
reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934,
as amended (the “Exchange Act”).
Any U.S. recipient of this research report wishing to effect any transaction to buy or sell securities or related
financial instruments based on the information provided in this research report should do so only through
Rosenblatt Securities Inc, 40 Wall Street 59th Floor, New York, NY 10005, a registered broker dealer in the
United States. Under no circumstances should any recipient of this research report effect any transaction to buy
or sell securities or related financial instruments through SinoPac. Rosenblatt Securities Inc. accepts
responsibility for the contents of this research report, subject to the terms set out below, to the extent that it is
delivered to a U.S. person other than a major U.S. institutional investor.
The analyst whose name appears in this research report is not registered or qualified as a research analyst with
the Financial Industry Regulatory Authority (“FINRA”) and may not be an associated person of Rosenblatt
Securities Inc. and, therefore, may not be subject to applicable restrictions under FINRA Rules on
communications with a subject company, public appearances and trading securities held by a research analyst
account.
Additional Disclosures
This research report is for distribution only under such circumstances as may be permitted by applicable law.
This research report has no regard to the specific investment objectives, financial situation or particular needs
of any specific recipient, even if sent only to a single recipient. This research report is not guaranteed to be a
complete statement or summary of any securities, markets, reports or developments referred to in this research
report. Neither SinoPac nor any of its directors, officers, employees or agents shall have any liability, however
7
arising, for any error, inaccuracy or incompleteness of fact or opinion in this research report or lack of care in
this research report’s preparation or publication, or any losses or damages which may arise from the use of this
research report.
SinoPac may rely on information barriers, such as “Chinese Walls” to control the flow of information within the
areas, units, divisions, groups, or affiliates of SinoPac.
Investing in any non-U.S. securities or related financial instruments (including ADRs) discussed in this research
report may present certain risks. The securities of non-U.S. issuers may not be registered with, or be subject to
the regulations of, the U.S. Securities and Exchange Commission. Information on such non-U.S. securities or
related financial instruments may be limited. Foreign companies may not be subject to audit and reporting
standards and regulatory requirements comparable to those in effect within the United States.
The value of any investment or income from any securities or related financial instruments discussed in this
research report denominated in a currency other than U.S. dollars is subject to exchange rate fluctuations that
may have a positive or adverse effect on the value of or income from such securities or related financial
instruments.
Past performance is not necessarily a guide to future performance and no representation or warranty, express
or implied, is made by SinoPac with respect to future performance. Income from investments may
fluctuate. The price or value of the investments to which this research report relates, either directly or indirectly,
may fall or rise against the interest of investors. Any recommendation or opinion contained in this research
report may become outdated as a consequence of changes in the environment in which the issuer of the
securities under analysis operates, in addition to changes in the estimates and forecasts, assumptions and
valuation methodology used herein.
No part of the content of this research report may be copied, forwarded or duplicated in any form or by any
means without the prior consent of SinoPac and SinoPac accepts no liability whatsoever for the actions of third
parties in this respect.